Navigation Links
Lifecycle Management Strategies: Pharma-Payer Deals - Creative agreements are used at different stages of the brand lifecycle to maximize sales

NEW YORK, Sept. 20, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue:


Lifecycle Management Strategies: Pharma-Payer Deals - Creative agreements are used at different stages of the brand lifecycle to maximize sales


With increasing cost-containment measures, payers have emerged as the key decision-making group, as proving the economic and clinical value of a drug is of central importance in achieving commercial success. As a result, pharma-payer deals have been used not only for launch products but also for mature brands in order to drive market share in the face of branded and generic competition alike.Analysis of success drivers and resistors of pharma-payer deals as a lifecycle management strategy.Discussion of how pharma-payer deals can satisfy key stakeholder needs.Case study of recent successful and unsuccessful pharma-payer deals.Risk-sharing agreements are based on a "guaranteed" outcome resulting from the treatment, be that based on financial or outcome/performance criteria. If the outcome is achieved the payer will pay; if not, the pharmaceutical company refunds the payer for the cost of the drug.Risk-sharing agreements have the potential to reconcile the needs of different stakeholders: pharma companies secure market entry, the payer is financially protected from patients who fail to respond to drug treatment, and patients gain access to innovative therapies.While straightforward discount and rebate deals are usually used to maintain sales later in the lifecycle when the drug in question is facing greater competition, recently, creative risk-sharing deals have also been used for mature brands in order to drive market share in the face of branded and generic competition alike.How can pharma-payer deals drive or maintain franchise sales?How can pharma-payer deals be used at different stages of a brand's lifecycle?In which markets are pharma-payer deals commonly used?





•Strategic scoping and focus

• Key findings

•Related reports


PHARMA-PAYER DEALS OVERVIEW•What are pharma-payer deals? - Early-stage risk-sharing deals to gain reimbursement approval

- Mid- to late-stage LCM pharma-payer deal strategies


•Drivers and resistors of pharma-payer deals as lifecycle management strategy

•Pharma-payer deals focus on satisfying payer needs

•Risk-sharing deals are increasing in numbers in the EU - Payer contracting becomes more creative in Germany


•US: deals with individual payer organizations are appearing

•Case study summary


PHARMA-PAYER DEALS CASE STUDIES•Januvia (sitagliptin) and Janumet (sitagliptin/metformin): Merck & Co. agrees performance-related discounts deal with Cigna - Lesson

- Background

- Impact


•Enbrel (etarnecept): Pfizer/Wyeth develop a compliance support program with German payer - Lesson

- Background

- Impact


•Aricept (donepezil): Pfizer/Eisai are testing "integrated care" to assess the cost-effectiveness and impact of its dementia drug Aricept - Lesson

- Background

- Impact


•Cimzia (certolizumab; UCB): positive recommendation in the UK is based on a patient access scheme - Lesson

- Background

- Impact


•Actonel (risendronate; Sanofi/Procter & Gamble): risk-sharing deal used to stave off both generic and branded competition - Lesson

- Background

- Impact


•Aclasta (zoledronic acid; Novartis): "no cure, no pay" deal used to boost uptake before new competitor entry - Lesson

- Background

- Impact



BIBLIOGRAPHY•Publications and online articles

•Datamonitor reports and products


APPENDIX•Exchange rates used in this report




•Table: Pharma-payer deals case studies summary

•Table: Currency exchange rates, 2011




•Figure: Early-stage risk-sharing agreements improve uptake and maximize peak sales

•Figure: Pharma-payer deals can be used in middle and later stages of the brand lifecycle to maximize peak sales and extend sales after patent expiry

•Figure: Drivers and resistors of pharma-payer deals as an LCM strategy

•Figure: Pharma-payer deals need to target key stakeholders' needs to be successful

•Figure: Benefits of a performance-based contract between Merck & Co. and Cigna

•Figure: Benefits of compliance support program between Pfizer/Wyeth and Taunus

•Figure: Benefits of Pfizer/Eisai and AOK dementia study

•Figure: Benefits of patient access scheme between UCB and NICE

•Figure: Actonel's risk-sharing deal in the US is used late in the brand lifecycle to stave off competing generics

•Figure: Aclasta pharma-payer deal in Germany




Companies Mentioned

Hutchison 3G UK Limited, Janssen Pharmaceuticals, Inc.




To order this report:

Drug_and_Medication Industry: Lifecycle Management Strategies: Pharma-Payer Deals - Creative agreements are used at different stages of the brand lifecycle to maximize sales


Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626


SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Accelrys ELN Advances Innovation Lifecycle Management with Enhanced Biology Capabilities from Screening to Preclinical Development
2. PAREXEL and Salem State University Launch Clinical Trial Management Graduate Program
3. Transdermal Pain Management to 2016: Products, Markets, Forecasts and Opportunities
4. Valeant Pharmaceuticals Announces Management Change
5. ConvaTec, A Leader In Antimicrobial Dressings And Infection Management, To Host Live International Webcast On Minimizing Risk Of Wound Infections
6. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
7. Launches New Medical Education Management Solutions That Meet ACGME NAS Accreditation Requirements
8. Saint Vincent Health System Selects onFocus Healthcare for Enterprise Performance Management
9. Global Airway Management Devices Industry
10. Selfhelp Community Services and FEGS Health & Human Services Launch New Care Management Company: SinglePoint Care Network to Coordinate Care for Seniors & Others With Chronic Medical Conditions in Managed Long Term Care Market
11. Actinium Pharmaceuticals Strengthens Management Team
Post Your Comments:
(Date:11/30/2015)... BOSTON , November 30, 2015 /PRNewswire/ ... potential new medicines directed at up to 10 G ... --> PFE ) to research and develop potential ... receptor (GPCR) targets across multiple therapeutic areas. --> ... discovery and development company and wholly-owned subsidiary of Sosei ...
(Date:11/29/2015)... Nov. 29, 2015  Strengthening its leadership in connected ... PHIA) today announced IntelliSpace Portal 8.0 , the ... visualization platform that helps radiologists detect, diagnose and follow-up ... Radiological Society of North America Annual Meeting (RSNA) ... 8.0 helps address the changing demands in radiology that ...
(Date:11/29/2015)... 2015   National Decision Support Company (NDSC) continues ... including notable statewide implementations. As a result, ordering ... Select, more than 1 million times per month—all ... Select provides real-time feedback on the most appropriate ... been implemented at over 100 healthcare systems nationally, ...
Breaking Medicine Technology:
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... The American ... campaign in honor of World AIDS Day 2015. On Nov. 30, ASCP shared its ... public awareness about World AIDS Day and the importance of getting tested for HIV. ...
(Date:11/30/2015)... ... 30, 2015 , ... According to RF Safe, the November ... at Consumer Reports as supporting a “A Call for Clarity” on cell phone ... original Nov 2015 CR story titled, “Does Cell-Phone Radiation Cause Cancer?” ...
(Date:11/30/2015)... , ... November 30, 2015 , ... While powdered supplements ... in wasted time. Fortunately, an inventor from Chesterfield, Va., has found an easy to ... keep the scoop used to measure powdered contents in a canister or other container ...
(Date:11/30/2015)... Ill. (PRWEB) , ... November 30, 2015 , ... ... Decision Support Solutions, announced at the Radiology Society of North America (RSNA) annual ... have seen over 60% growth from 2014. Throughout 2015, the company has ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... suite of automated breast density assessment and enterprise analytics solutions, here at ... 4, 2015 (South Hall booth #2377). Volpara’s quantitative breast imaging tools enable ...
Breaking Medicine News(10 mins):